An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Clinical trial NCT02890992 · COMPLETED
Trial details
- NCT number
- NCT02890992
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2018-09-13
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.